Skip to main content
Fig. 4 | BMC Veterinary Research

Fig. 4

From: Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial

Fig. 4

WSAVA histologic scores (overall and for each specific tissue–stomach, colon and duodenum) in groups A (placebo) and B (supplement) at initial visit (1) and after 180 days of treatment (2; 195 days after initial visit) treatment. Asterisks indicate statistical significance compared to pretreatment (t = 0 days) values (one-way ANOVA; *p < 0.05; **p < 0.01; ns not statistically significant)

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us